跳至主要内容
临床试验/ISRCTN44033252
ISRCTN44033252已完成未知

Optimizing place of treatment for young infants presenting with any low-mortality-risk sign of possible serious bacterial infection.

World Health Organization0 个研究点目标入组 7,002 人开始时间: 2021年1月20日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
7,002

研究概览

简要总结

2023 Protocol article in https://pubmed.ncbi.nlm.nih.gov/37449353/ (added 17/07/2023)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Aged <2 months
  • 2. Living in a geographic area where follow-up for 14 days can be accomplished
  • 3. Presenting to outpatient clinics or emergency rooms of participating hospitals with only one of the following low-risk signs of PSBI:
  • 3.1. Body temperature =38°C
  • 3.2. Severe chest indrawing
  • 3.3. Fast breathing if aged <7 days

排除标准

  • 1. Weight for age <-3 z, or weight <2 kg at the time of presentation if age at screening is less than 10 days
  • 2. Signs of critical illness (no movement at all, unable to feed at all, or convulsions)
  • 3. Signs of clinical severe infection (CSI) associated with a moderate risk of mortality (stopped feeding well, movement only on stimulation, low body temperature <35.5°C, or two or more of the six signs of CSI)
  • 4. Any sign suggestive of another serious illness/condition, such as but not limited to: major congenital malformations, severe jaundice, conditions requiring major surgery, meningitis, bone or joint infection, or severe dehydration
  • 5. Appearance of low-mortality risk signs in the first 24 h of life
  • 6. Hospitalized for any illness in the previous 2 weeks
  • 7. Prior use of injectable antibiotics for the same illness
  • 8. Previously included in this study or currently included in any other study

研究者

相似试验

Optimal place of treatment for young infants aged... | 临床试验